Predictors of uptake and timeliness of newly introduced pneumococcal and rotavirus vaccines, and of measles vaccine in rural malawi: a population cohort study.

Background<br> Malawi introduced pneumococcal conjugate vaccine (PCV13) and monovalent rotavirus vaccine (RV1) in 2011 and 2012 respectively, and is planning the introduction of a second-dose measles vaccine (MV). We assessed predictors of availability, uptake and timeliness of these vaccines...

Full description

Bibliographic Details
Main Authors: Heinsbroek, E, Chihana, M, Crampin, AC, Kabuluzi, S, Chirwa, G, Mwansambo, C, Costello, A, Cunliffe, NA, Heyderman, RS, French, N, Bar-Zeev, N, Lewycka, S, VacSurv Consortium
Format: Journal article
Language:English
Published: Public Library of Science 2016
_version_ 1826294737944969216
author Heinsbroek, E
Chihana, M
Crampin, AC
Kabuluzi, S
Chirwa, G
Mwansambo, C
Costello, A
Cunliffe, NA
Heyderman, RS
French, N
Bar-Zeev, N
Lewycka, S
VacSurv Consortium
author_facet Heinsbroek, E
Chihana, M
Crampin, AC
Kabuluzi, S
Chirwa, G
Mwansambo, C
Costello, A
Cunliffe, NA
Heyderman, RS
French, N
Bar-Zeev, N
Lewycka, S
VacSurv Consortium
author_sort Heinsbroek, E
collection OXFORD
description Background<br> Malawi introduced pneumococcal conjugate vaccine (PCV13) and monovalent rotavirus vaccine (RV1) in 2011 and 2012 respectively, and is planning the introduction of a second-dose measles vaccine (MV). We assessed predictors of availability, uptake and timeliness of these vaccines in a rural Malawian setting. <br> Methods<br> Commencing on the first date of PCV13 eligibility we conducted a prospective population-based birth cohort study of 2,616 children under demographic surveillance in Karonga District, northern Malawi who were eligible for PCV13, or from the date of RV1 introduction both PCV13 and RV1. Potential predictors of vaccine uptake and timeliness for PCV13, RV1 and MV were analysed respectively using robust Poisson and Cox regression. <br> Results<br> Vaccine coverage was high for all vaccines, ranging from 86.9% for RV1 dose 2 to 95.4% for PCV13 dose 1. Median time delay for PCV13 dose 1 was 17 days (IQR 7–36), 19 days (IQR 8–36) for RV1 dose 1 and 20 days (IQR 3–46) for MV. Infants born to lower educated or farming mothers and those living further away from the road or clinic were at greater risk of being not fully vaccinated and being vaccinated late. Delays in vaccination were also associated with non-facility birth. Vaccine stock-outs resulted in both a delay in vaccine timeliness and in a decrease in completion of schedule. <br> Conclusion<br> Despite high vaccination coverage in this setting, delays in vaccination were common. We identified programmatic and socio-demographic risk factors for uptake and timeliness of vaccination. Understanding who remains most vulnerable to be unvaccinated allows for focussed delivery thereby increasing population coverage and maximising the equitable benefits of universal vaccination programmes.
first_indexed 2024-03-07T03:50:18Z
format Journal article
id oxford-uuid:c1015963-8354-4761-aac9-2ed6503317a9
institution University of Oxford
language English
last_indexed 2024-03-07T03:50:18Z
publishDate 2016
publisher Public Library of Science
record_format dspace
spelling oxford-uuid:c1015963-8354-4761-aac9-2ed6503317a92022-03-27T05:58:27ZPredictors of uptake and timeliness of newly introduced pneumococcal and rotavirus vaccines, and of measles vaccine in rural malawi: a population cohort study.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:c1015963-8354-4761-aac9-2ed6503317a9EnglishSymplectic ElementsPublic Library of Science2016Heinsbroek, EChihana, MCrampin, ACKabuluzi, SChirwa, GMwansambo, CCostello, ACunliffe, NAHeyderman, RSFrench, NBar-Zeev, NLewycka, SVacSurv ConsortiumBackground<br> Malawi introduced pneumococcal conjugate vaccine (PCV13) and monovalent rotavirus vaccine (RV1) in 2011 and 2012 respectively, and is planning the introduction of a second-dose measles vaccine (MV). We assessed predictors of availability, uptake and timeliness of these vaccines in a rural Malawian setting. <br> Methods<br> Commencing on the first date of PCV13 eligibility we conducted a prospective population-based birth cohort study of 2,616 children under demographic surveillance in Karonga District, northern Malawi who were eligible for PCV13, or from the date of RV1 introduction both PCV13 and RV1. Potential predictors of vaccine uptake and timeliness for PCV13, RV1 and MV were analysed respectively using robust Poisson and Cox regression. <br> Results<br> Vaccine coverage was high for all vaccines, ranging from 86.9% for RV1 dose 2 to 95.4% for PCV13 dose 1. Median time delay for PCV13 dose 1 was 17 days (IQR 7–36), 19 days (IQR 8–36) for RV1 dose 1 and 20 days (IQR 3–46) for MV. Infants born to lower educated or farming mothers and those living further away from the road or clinic were at greater risk of being not fully vaccinated and being vaccinated late. Delays in vaccination were also associated with non-facility birth. Vaccine stock-outs resulted in both a delay in vaccine timeliness and in a decrease in completion of schedule. <br> Conclusion<br> Despite high vaccination coverage in this setting, delays in vaccination were common. We identified programmatic and socio-demographic risk factors for uptake and timeliness of vaccination. Understanding who remains most vulnerable to be unvaccinated allows for focussed delivery thereby increasing population coverage and maximising the equitable benefits of universal vaccination programmes.
spellingShingle Heinsbroek, E
Chihana, M
Crampin, AC
Kabuluzi, S
Chirwa, G
Mwansambo, C
Costello, A
Cunliffe, NA
Heyderman, RS
French, N
Bar-Zeev, N
Lewycka, S
VacSurv Consortium
Predictors of uptake and timeliness of newly introduced pneumococcal and rotavirus vaccines, and of measles vaccine in rural malawi: a population cohort study.
title Predictors of uptake and timeliness of newly introduced pneumococcal and rotavirus vaccines, and of measles vaccine in rural malawi: a population cohort study.
title_full Predictors of uptake and timeliness of newly introduced pneumococcal and rotavirus vaccines, and of measles vaccine in rural malawi: a population cohort study.
title_fullStr Predictors of uptake and timeliness of newly introduced pneumococcal and rotavirus vaccines, and of measles vaccine in rural malawi: a population cohort study.
title_full_unstemmed Predictors of uptake and timeliness of newly introduced pneumococcal and rotavirus vaccines, and of measles vaccine in rural malawi: a population cohort study.
title_short Predictors of uptake and timeliness of newly introduced pneumococcal and rotavirus vaccines, and of measles vaccine in rural malawi: a population cohort study.
title_sort predictors of uptake and timeliness of newly introduced pneumococcal and rotavirus vaccines and of measles vaccine in rural malawi a population cohort study
work_keys_str_mv AT heinsbroeke predictorsofuptakeandtimelinessofnewlyintroducedpneumococcalandrotavirusvaccinesandofmeaslesvaccineinruralmalawiapopulationcohortstudy
AT chihanam predictorsofuptakeandtimelinessofnewlyintroducedpneumococcalandrotavirusvaccinesandofmeaslesvaccineinruralmalawiapopulationcohortstudy
AT crampinac predictorsofuptakeandtimelinessofnewlyintroducedpneumococcalandrotavirusvaccinesandofmeaslesvaccineinruralmalawiapopulationcohortstudy
AT kabuluzis predictorsofuptakeandtimelinessofnewlyintroducedpneumococcalandrotavirusvaccinesandofmeaslesvaccineinruralmalawiapopulationcohortstudy
AT chirwag predictorsofuptakeandtimelinessofnewlyintroducedpneumococcalandrotavirusvaccinesandofmeaslesvaccineinruralmalawiapopulationcohortstudy
AT mwansamboc predictorsofuptakeandtimelinessofnewlyintroducedpneumococcalandrotavirusvaccinesandofmeaslesvaccineinruralmalawiapopulationcohortstudy
AT costelloa predictorsofuptakeandtimelinessofnewlyintroducedpneumococcalandrotavirusvaccinesandofmeaslesvaccineinruralmalawiapopulationcohortstudy
AT cunliffena predictorsofuptakeandtimelinessofnewlyintroducedpneumococcalandrotavirusvaccinesandofmeaslesvaccineinruralmalawiapopulationcohortstudy
AT heydermanrs predictorsofuptakeandtimelinessofnewlyintroducedpneumococcalandrotavirusvaccinesandofmeaslesvaccineinruralmalawiapopulationcohortstudy
AT frenchn predictorsofuptakeandtimelinessofnewlyintroducedpneumococcalandrotavirusvaccinesandofmeaslesvaccineinruralmalawiapopulationcohortstudy
AT barzeevn predictorsofuptakeandtimelinessofnewlyintroducedpneumococcalandrotavirusvaccinesandofmeaslesvaccineinruralmalawiapopulationcohortstudy
AT lewyckas predictorsofuptakeandtimelinessofnewlyintroducedpneumococcalandrotavirusvaccinesandofmeaslesvaccineinruralmalawiapopulationcohortstudy
AT vacsurvconsortium predictorsofuptakeandtimelinessofnewlyintroducedpneumococcalandrotavirusvaccinesandofmeaslesvaccineinruralmalawiapopulationcohortstudy